<SEC-DOCUMENT>0001157523-23-001387.txt : 20230905
<SEC-HEADER>0001157523-23-001387.hdr.sgml : 20230905
<ACCEPTANCE-DATETIME>20230901181808
ACCESSION NUMBER:		0001157523-23-001387
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20230901
FILED AS OF DATE:		20230905
DATE AS OF CHANGE:		20230901

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ORGANIGRAM HOLDINGS INC.
		CENTRAL INDEX KEY:			0001620737
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			Z4
		FISCAL YEAR END:			0831

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38885
		FILM NUMBER:		231233613

	BUSINESS ADDRESS:	
		STREET 1:		35A ENGLISH DR.
		CITY:			MONCTON
		STATE:			A3
		ZIP:			E1E 3X3
		BUSINESS PHONE:		506-384-1571

	MAIL ADDRESS:	
		STREET 1:		35A ENGLISH DR.
		CITY:			MONCTON
		STATE:			A3
		ZIP:			E1E 3X3

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ORGANIGRAM HOLDINGS INC
		DATE OF NAME CHANGE:	20140926
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>a53548005.htm
<DESCRIPTION>ORGANIGRAM HOLDINGS INC. 6-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Business Wire
         Document created using Broadridge PROfile 23.7.1.5162
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">


  <div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold;">UNITED STATES</div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="text-align: center; font-weight: bold;">Washington, D.C. 20549</div>
    <div><br>
    </div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold;">FORM 6-K</div>
    <div><br>
    </div>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold;">REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934</div>
    <div>&#160;</div>
    <div style="text-align: center;">For the month of September 2023</div>
    <div>&#160;</div>
    <div style="text-align: center;">Commission File Number: <font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>001-38885</u></font></div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold;"><u>ORGANIGRAM HOLDINGS INC.</u></div>
    <div style="text-align: center;">(Translation of registrant&#8217;s name into English)</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">145 King Street West, Suite 1400</div>
    <div style="text-align: center; font-weight: bold;"><u>Toronto, Ontario, Canada M5H 1J8</u></div>
    <div style="text-align: center;"><font style="font-weight: bold;">&#160;</font>(Address of principal
        executive offices)</div>
    <div><br>
    </div>
    <div>&#160;</div>
    <div>Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</div>
    <div>&#160;</div>
    <div style="text-align: center;">Form 20-F&#160;[&#160; ]<font class="TRGRRTFtoHTMLTab" style="text-indent: 0px;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">Form 40-F&#160;[ X ]</font></div>
    <div>&#160;</div>
    <div style="text-align: justify;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):&#160;&#160;[&#160; ]</div>
    <div>&#160;</div>
    <div style="text-align: justify;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):&#160; [&#160; ]</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">SUBMITTED HEREWITH</div>
    <div><br>
    </div>
    <div style="font-weight: bold;"><u>Exhibits</u></div>
    <table cellspacing="0" cellpadding="0" border="0" id="z19fff6b603dd46e2baec818632311e7d" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(255, 255, 255); font-family: 'Times New Roman',Times,serif;">
            <div><a href="a53548005ex99_1.htm">99.1</a></div>
          </td>
          <td style="width: 95%; vertical-align: top; background-color: rgb(255, 255, 255); font-family: 'Times New Roman',Times,serif;">
            <div><a href="a53548005ex99_1.htm">News release dated September 1, 2023</a></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">SIGNATURE</div>
    <div><br>
    </div>
    <div>Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
      thereunto duly authorized.</div>
    <div><br>
    </div>
    <div style="font-weight: bold;">ORGANIGRAM HOLDINGS INC.</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><u>/s/ Derrick West</u>&#160; &#160; &#160; &#160; &#160;&#160;<u> </u></div>
    <div>Derrick West</div>
    <div>Chief Financial Officer</div>
    <div><br>
    </div>
    <div>Date: September 1, 2023</div>
  </div>


</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a53548005ex99_1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Business Wire
         Document created using Broadridge PROfile 23.7.1.5162
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 99.1</font><br>
  </div>
  <div style="text-align: right;"><font style="font-weight: bold;"> <br>
    </font></div>
  <div>
    <div class="bw-release">
      <h1 style="text-align: center; list-style-position: inside;FONT-SIZE: 14pt;"> <b>Organigram Announces Resignation of Board Member</b> </h1>
      <div class="bw-release-body">
        <div class="bw-release-table-js bw-release-story">
          <p>TORONTO--(BUSINESS WIRE)--September 1, 2023--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the &#8220;Company&#8221; or &#8220;Organigram&#8221;), a leading licensed producer of cannabis, announces today that Ms. Caroline Ferland has resigned from the Board of
            Directors (&#8220;the Board&#8221;) effective immediately. Ms. Ferland was a board member nominee appointed by BAT. </p>
          <p> &#8220;In her short time on the Board, Ms. Ferland made considerable contributions to Organigram,&#8221; said Peter Amirault, Chair of Organigram&#8217;s Board of Directors. &#8220;In addition to providing meaningful involvement on the strategic planning and
            corporate governance fronts, Ms. Ferland used her extensive international experience in legal and regulatory matters to support the Company, providing solid strategic guidance on several matters.&#8221; </p>
          <p> Ms. Ferland is leaving Organigram&#8217;s Board of Directors as a result of her appointment to Group Company Secretary &amp; Assistant General Counsel for BAT, based in the UK. The Board of Directors and the Company&#8217;s management team would like to
            thank Ms. Ferland for her valuable contributions to Organigram and wish her well in her new role. </p>
          <p> BAT has informed Organigram that it expects to appoint a replacement nominee in due course Simon Ashton continues to serve on the Board as one of BATs two contractual nominees. </p>
          <div> </div>
          <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" id="DSPFPageBreakArea">
            <div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
              <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
          </div>
          <p> <b>About Organigram Holdings Inc. <br>
            </b>Organigram Holdings Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiaries include: Organigram Inc. and Laurentian Organic Inc., licensed producers of cannabis and cannabis-derived products in Canada,
            and The Edibles and Infusions Corporation, a licensed manufacturer of cannabis-infused edibles in Canada. </p>
          <p> Organigram is focused on producing high-quality, cannabis for patients and adult recreational consumers, as well as developing international business partnerships to extend the Company&#8217;s global footprint. Organigram has also developed and
            acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O&#8217; Buds, SHRED, SHRED&#8217;ems, Monjour, Laurentian, Tremblant Cannabis and Trailblazer. Organigram operates facilities in Moncton, New
            Brunswick and Lac-Sup&#233;rieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada). </p>
          <p> <b>Forward-Looking Information <br>
            </b>This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as &#8220;plans&#8221;, &#8220;expects&#8221;, &#8220;estimates&#8221;, &#8220;intends&#8221;, &#8220;anticipates&#8221;, &#8220;believes&#8221; or variations of
            such words and phrases or state that certain actions, events, or results &#8220;may&#8221;, &#8220;could&#8221;, &#8220;would&#8221;, &#8220;might&#8221; or &#8220;will&#8221; be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors
            that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in
            this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such
            forward-looking information include factors and risks as disclosed in the Company&#8217;s most recent annual information form, management&#8217;s discussion and analysis and other Company documents filed from time to time on SEDAR (see www.sedar.com) and
            filed or furnished to the Securities and Exchange Commission on EDGAR (see www.sec.gov). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Although the
            Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will
            occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by
            law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. </p>
          <div> </div>
          <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" id="DSPFPageBreakArea">
            <div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
              <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
          </div>
        </div>
        <div class="bw-release-contact">
          <h2 style="FONT-SIZE: 14pt;">Contacts</h2>
          <p> <b>For Investor Relations enquiries: </b><br>
            <b>Max Schwartz </b><br>
            Director of Investor Relations <br>
            investors@organigram.ca<br>
            Organigram </p>
          <p> <b>For Media enquiries: </b><br>
            <b>Megan McCrae </b><br>
            Senior Vice President of Marketing and Communications <br>
            megan.mccrae@organigram.ca<br>
            Organigram </p>
        </div>
      </div>
    </div>
    <font style="font-weight: bold;"> </font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
